Nosho Shuji, Tosa Ikue, Ono Mitsuaki, Hara Emilio Satoshi, Ishibashi Kei, Mikai Akihiro, Tanaka Yukie, Kimura-Ono Aya, Komori Taishi, Maekawa Kenji, Kuboki Takuo, Oohashi Toshitaka
Department of Molecular Biology and Biochemistry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.
Department of Oral Rehabilitation and Regenerative Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.
Int J Mol Sci. 2020 Oct 27;21(21):7967. doi: 10.3390/ijms21217967.
Bone morphogenetic protein-2 (BMP-2) and fibroblast growth factor-2 (FGF-2) have been regarded as the major cytokines promoting bone formation, however, several studies have reported unexpected results with failure of bone formation or bone resorption of these growth factors. In this study, BMP-2 and FGF-2 adsorbed into atellocollagen sponges were transplanted into bone defects in the bone marrow-scarce calvaria (extramedullary environment) and bone marrow-abundant femur (medullary environment) for analysis of their in vivo effects not only on osteoblasts, osteoclasts but also on bone marrow cells. The results showed that BMP-2 induced high bone formation in the bone marrow-scarce calvaria, but induced bone resorption in the bone marrow-abundant femurs. On the other hand, FGF-2 showed opposite effects compared to those of BMP-2. Analysis of cellular dynamics revealed numerous osteoblasts and osteoclasts present in the newly-formed bone induced by BMP-2 in calvaria, but none were seen in either control or FGF-2-transplanted groups. On the other hand, in the femur, numerous osteoclasts were observed in the vicinity of the BMP-2 pellet, while a great number of osteoblasts were seen near the FGF-2 pellets or in the control group. Of note, FCM analysis showed that both BMP-2 and FGF-2 administrated in the femur did not significantly affect the hematopoietic cell population, indicating a relatively safe application of the two growth factors. Together, these results indicate that BMP-2 could be suitable for application in extramedullary bone regeneration, whereas FGF-2 could be suitable for application in medullary bone regeneration.
骨形态发生蛋白-2(BMP-2)和成纤维细胞生长因子-2(FGF-2)被视为促进骨形成的主要细胞因子,然而,多项研究报告了意想不到的结果,即这些生长因子未能促进骨形成或导致骨吸收。在本研究中,将吸附于脱细胞胶原海绵的BMP-2和FGF-2移植到骨髓稀缺的颅骨(髓外环境)和骨髓丰富的股骨(髓内环境)的骨缺损处,以分析它们在体内对成骨细胞、破骨细胞以及骨髓细胞的影响。结果显示,BMP-2在骨髓稀缺的颅骨中诱导了高骨形成,但在骨髓丰富的股骨中诱导了骨吸收。另一方面,FGF-2的作用与BMP-2相反。细胞动力学分析显示,BMP-2在颅骨中诱导形成的新骨中有大量成骨细胞和破骨细胞,但在对照组或FGF-2移植组中均未观察到。另一方面,在股骨中,在BMP-2微球附近观察到大量破骨细胞,而在FGF-2微球附近或对照组中则可见大量成骨细胞。值得注意的是,流式细胞术分析表明,在股骨中施用的BMP-2和FGF-2均未显著影响造血细胞群体,表明这两种生长因子的应用相对安全。总之,这些结果表明,BMP-2适用于髓外骨再生,而FGF-2适用于髓内骨再生。